Treatment Strategy for Rifampin-Susceptible Tuberculosis
N Engl J Med
.
2023 Jun 15;388(24):2297.
doi: 10.1056/NEJMc2304776.
Authors
Martin J Boeree
1
,
Norbert Heinrich
2
,
Rob E Aarnoutse
3
Affiliations
1
Radboud University Medical Center, Nijmegen, the Netherlands martin.boeree@radboudumc.nl.
2
Ludwig Maximilian University of Munich, Munich, Germany.
3
Radboud University Medical Center, Nijmegen, the Netherlands.
PMID:
37314715
DOI:
10.1056/NEJMc2304776
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Rifampin* / therapeutic use
Tuberculosis* / drug therapy
Substances
Rifampin